Search alternatives:
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
43061
-
43062
-
43063
-
43064
Data_Sheet_1_Sleep duration and depression among adolescents: Mediation effect of collective integration.docx
Published 2022“…The analytic sample in the present study included 8,829 seventh-grade students aged about 14 years (51.50% boys and 48.50% girls). A structural equation modeling (SEM) was used to investigate parent–child/teacher factors affecting adolescent sleep duration and depression, and Monte Carlo resampling with R was employed to confirm the significance of the mediation effects of collective integration. …”
-
43065
-
43066
Table3_Indications and adverse events of teriparatide: based on FDA adverse event reporting system (FAERS).DOCX
Published 2024“…</p>Results<p>Out of 107,123 reports with teriparatide as the primary suspect, key AEs identified included pain in extremity (PRR: 4.54), muscle spasms (PRR: 5.11), fractures (PRR range: 17.67–552.95), and increased calcium levels (PRR: 50.73). Teriparatide exhibited a stronger association with increased calcium levels (PRR: 50.73) compared to fractures (PRR range: 17.67–552.95). …”
-
43067
Table 1_Concomitant autoimmunity and late cancers in adult-onset immunodeficiency due to neutralizing anti-IFN-γ autoantibodies.docx
Published 2025“…</p>Methods<p>This study included 50 patients diagnosed with adult-onset immunodeficiency due to nAIGA between 2014-2024. …”
-
43068
-
43069
-
43070
-
43071
-
43072
-
43073
Table4_Indications and adverse events of teriparatide: based on FDA adverse event reporting system (FAERS).DOCX
Published 2024“…</p>Results<p>Out of 107,123 reports with teriparatide as the primary suspect, key AEs identified included pain in extremity (PRR: 4.54), muscle spasms (PRR: 5.11), fractures (PRR range: 17.67–552.95), and increased calcium levels (PRR: 50.73). Teriparatide exhibited a stronger association with increased calcium levels (PRR: 50.73) compared to fractures (PRR range: 17.67–552.95). …”
-
43074
-
43075
-
43076
-
43077
-
43078
-
43079
-
43080
Table7_Indications and adverse events of teriparatide: based on FDA adverse event reporting system (FAERS).DOCX
Published 2024“…</p>Results<p>Out of 107,123 reports with teriparatide as the primary suspect, key AEs identified included pain in extremity (PRR: 4.54), muscle spasms (PRR: 5.11), fractures (PRR range: 17.67–552.95), and increased calcium levels (PRR: 50.73). Teriparatide exhibited a stronger association with increased calcium levels (PRR: 50.73) compared to fractures (PRR range: 17.67–552.95). …”